While contemporary findings indicate that increases in C3 complement activation occur in seizure disorders [reviewed in Wyatt-Johnson and Brewster (2020)], the specific pathophysiological consequences in epilepsy remain to be elucidated. This evidence concerns the gene C3 and epilepsy.